158 related articles for article (PubMed ID: 38732153)
1. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
Zhang BS; Zhang XM; Ito M; Yajima S; Yoshida K; Ohno M; Nishi E; Wang H; Li SY; Kubota M; Yoshida Y; Matsutani T; Mine S; Machida T; Takemoto M; Yamagata H; Hayashi A; Yokote K; Kobayashi Y; Takizawa H; Kuroda H; Shimada H; Iwadate Y; Hiwasa T
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732153
[TBL] [Abstract][Full Text] [Related]
2. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
[TBL] [Abstract][Full Text] [Related]
4. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.
Li SY; Yoshida Y; Kubota M; Zhang BS; Matsutani T; Ito M; Yajima S; Yoshida K; Mine S; Machida T; Hayashi A; Takemoto M; Yokote K; Ohno M; Nishi E; Kitamura K; Kamitsukasa I; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Iwase K; Shimada H; Iwadate Y; Hiwasa T
Front Cardiovasc Med; 2023; 10():1042272. PubMed ID: 36844744
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer.
Yoshida K; Hiwasa T; Ito M; Ushigome M; Takizawa H; Li SY; Zhang BS; Iwadate Y; Funahashi K; Shimada H
Oncol Lett; 2023 Mar; 25(3):127. PubMed ID: 36844622
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.
Kubota M; Yoshida Y; Kobayashi E; Matsutani T; Li SY; Zhang BS; Mine S; Machida T; Takizawa H; Hiwasa T; Iwadate Y
Sci Rep; 2021 Nov; 11(1):21772. PubMed ID: 34741085
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
[TBL] [Abstract][Full Text] [Related]
10. Jumonji domain-containing protein 6 protein and its role in cancer.
Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
[TBL] [Abstract][Full Text] [Related]
11. High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.
Zhang J; Ni SS; Zhao WL; Dong XC; Wang JL
Tumour Biol; 2013 Aug; 34(4):2397-401. PubMed ID: 23595221
[TBL] [Abstract][Full Text] [Related]
12. JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma.
Liu H; Jiang M; Ma F; Qin J; Zhou X; Xu L; Yan X; Jiang T
BMC Cancer; 2023 Jul; 23(1):696. PubMed ID: 37488513
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
[TBL] [Abstract][Full Text] [Related]
14. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
Wang H; Lu H; Zhang XM; Goto KI; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kamitsukasa I; Wada T; Aotsuka A; Sugimoto K; Takizawa H; Kashiwado K; Shin H; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Xu A; Hiwasa T
BMC Neurol; 2021 Jul; 21(1):274. PubMed ID: 34243715
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and micro-anatomic characterization of a cell-adapted mutant foot-and-mouth disease virus in cattle: Impact of the Jumonji C-domain containing protein 6 (JMJD6) and route of inoculation.
Lawrence P; Pacheco J; Stenfeldt C; Arzt J; Rai DK; Rieder E
Virology; 2016 May; 492():108-17. PubMed ID: 26914509
[TBL] [Abstract][Full Text] [Related]
16. The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.
Rosager AM; Dahlrot RH; Sørensen MD; Bangsø JA; Hansen S; Kristensen BW
J Neuropathol Exp Neurol; 2022 Jan; 81(1):54-60. PubMed ID: 34875075
[TBL] [Abstract][Full Text] [Related]
17. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
[TBL] [Abstract][Full Text] [Related]
18. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
19. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma.
Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Sumazaki M; Shiratori F; Wang H; Hu L; Takizawa H; Li SY; Iwadate Y; Hiwasa T; Shimada H
Med Int (Lond); 2023; 3(2):11. PubMed ID: 36875818
[TBL] [Abstract][Full Text] [Related]
20. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
Front Oncol; 2022; 12():870086. PubMed ID: 35656505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
